Head-to-head · Cost-Efficiency Index
LaSara Medical Group vs HumeCare+
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
LaSara Medical Group
Shoppers who want a hybrid in-person/telehealth GLP-1 option in Southern California and are comfortable prepaying a year for the lowest rate.
Visit LaSara Medical GroupHumeCare+
Cost-first shoppers who want not currently recommendable -- pricing is unverifiable and regulatory signals are internally inconsistent.
Visit HumeCare+The verdict
LaSara Medical Group takes it, leading the Cost-Efficiency Index 45 to 42. LaSara Medical Group is a hybrid national-telehealth-plus-Southern-California-in-person provider selling compounded semaglutide (from $299/mo month-to-month, down to $233/mo equivalent on a $2,795 12-month prepay) and tirzepatide (from $399/mo, down to $325/mo equivalent on a $3,895 12-month prepay). HumeCare+ still earns a C — Cost-first shoppers who want not currently recommendable -- pricing is unverifiable and regulatory signals are internally inconsistent.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs LaSara Medical Group.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | LaSara Medical Group | HumeCare+ |
|---|---|---|
| Cost-Efficiency Index | 45/100 | 42/100 |
| Semaglutide / mo | $299/mo (starting dose, compounded) | $199/mo (a floor, not the price: visible only after the medical intake; plus a separate fee at enrollment and every refill, never published; no dose stated, compounded) |
| Tirzepatide / mo | $399/mo (starting dose, compounded) | $299/mo (visible only after the medical intake; plus a separate fee at enrollment and every refill, never published; no dose stated, compounded) |
| Semaglutide / yr (modeled) | $3,588 | — |
| Tirzepatide / yr (modeled) | $4,788 | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #465 | #470 |
LaSara Medical Group
45/100Where the value is
- Full, clean 4-tier pricing tables published for both drugs with exact dollar totals at every commitment length — real transparency, no gating behind intake
- Named clinical leadership: Medical Director Dr. Sunil Kurup and Founder/CEO John Snedegar
- Rare hybrid model — national telehealth plus an actual in-person Southern California option, alongside a broader hormone/peptide menu (TRT, NAD+, sermorelin, B12, enclomiphene)
The tradeoffs
- The lowest advertised per-month figures ($233 sema / $325 tirz) require a full 12-month prepay charged upfront ($2,795 / $3,895 at once) — the real month-to-month price is $299 / $399, 28-33% higher
- States served are not disclosed anywhere on the pricing pages despite the 'national telehealth' claim
HumeCare+
42/100Where the value is
- Genuinely prescribes semaglutide or tirzepatide via a named physician (Dr. Aaron Carter, MD, CMO)
- Includes muscle-preservation supplementation (glycine, B12, B6) as standard
- Proprietary 'Hume Pod' body-composition tracking device is a differentiated feature
The tradeoffs
- No actual price could be found anywhere on the live site -- the pricing template shows an unfilled '$[X]/mo' placeholder
- Regulatory badges shown are UK bodies (GPhC, CQC, MHRA) despite the site's own 'USA's No. 1' claim -- an unexplained inconsistency
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.